Primary hepatic neuroendocrine tumor: Five cases with different preoperative diagnoses

Turkish Journal of Gastroenterology

Volumn 23, Issue 3, 2012, Pages 272-278

  Yalav, Orçun ^a   Ülkü, Abdullah ^a   Akçam, Tolga Atilgan ^a   Demiryürek, Haluk ^a   Doran, Figen ^b  

^a CUKUROVA UNIVERSITY   (Turkey)

^b CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Carcinoid; Liver; Primary hepatic neuroendocrine tumor

Indexed keywords

ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; CHROMOGRANIN A; MEMBRANE PROTEIN; NEURON SPECIFIC ENOLASE;

ABDOMINAL PAIN; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEMANGIOMA; HUMAN; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; MORTALITY; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY HEPATIC NEUROENDOCRINE TUMOR; PROTEIN BLOOD LEVEL; SYNAPTIC MEMBRANE; TUMOR BLEEDING; TUMOR DIAGNOSIS; TUMOR RECURRENCE;

ADULT; CHEMOEMBOLIZATION, THERAPEUTIC; COLONOSCOPY; ENDOSCOPY, GASTROINTESTINAL; FEMALE; HEPATECTOMY; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROENDOCRINE TUMORS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

EID: 84866479630     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: 10.4318/tjg.2012.0465     Document Type: Article

References (28)

1. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997; 79: 813-29.
2. Maggard MA, O'Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg 2004; 240: 117-22.
3. Edmondson H. Tumor of the liver and intrahepatic bile duct. Atlas of tumor pathology, section 7, fascicle 25. Washington, DC: Armed Forces Institute of Pathology, 1958; 105-9.
4. Godwin II JD. Carcinoid tumors. An analysis of 2837 cases. Cancer 1975; 36: 560-9.
5. Williams ED, Sandler M. The classification of carcinoid tumors. Lancet 1963; 1: 238-9.
6. Solcia E, Kloppel G, Sobin LH. WHO histological typing of endocrine tumours. 2nd ed. Berlin: Springer, 2000.
7. Oberg K, Astrup L, Eriksson B, et al. Guidelines for the management of gastroenteropancreatic neuroendocrine tumors (including bronchopulmonary and thymic neoplasms). Part I-general overview. Acta Oncol 2004; 43: 617-25.
8. Donadon M, Torzilli G, Palmisano A, et al. Liver resection for primary hepatic neuroendocrine tumours: report of three cases and review of the literature. Eur J Surg Oncol 2006; 32: 325-8.
9. Mehta DC, Warner RR, Parnes I, Weiss M. An 18-year follow-up of primary hepatic carcinoid with carcinoid syndrome. J Clin Gastroenterol 1996; 23: 60-2.
10. Kaya G, Pasche C, Osterheld MC, Chaubert P, Fontolliet C. Primary neuroendocrine carcinoma of the liver: an autopsy case. Pathol Int 2001; 51: 874-8.
11. Lamberts SW, Hofland LJ, Nobels FR. Neuroendocrine tumor markers. Front Neuroendocrinol 2001; 22: 309-39.
12. Campana D, Nori F, Piscitelli L, et al. Chromogranin A: is it a useful marker of neuroendocrine tumors? J Clin Oncol 2007; 25: 1967-73.
13. Erikson B, Oberg K, Stridsberg M. Tumor markers in neuroendocrine tumors. Digestion 2000; 62: 33-8.
14. van der Hoef M, Crook DW, Marincek B, Weishaupt D. Primary neuroendocrine tumors of the liver: MRI features in two cases. Abdom Imaging 2004; 29: 77-81.
15. Sippel RS, Chen H. Carcinoid tumors. Surg Oncol Clin N Am 2006; 15: 463-78.
16. Orlefors H, Sundin A, Garske U, et al. Whole-body (11)C-5- hydroxytryptophan positron emission tomography as a universal imaging technique for neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and computed tomography. J Clin Endocrinol Metab 2005; 90: 3392-400.
17. Kwekkeboom DJ, Krenning EP. Somatostatin receptor imaging. Semin Nucl Med 2002; 32: 84-91.
18. Tamm EP, Kim EE, Ng CS. Imaging of neuroendocrine tumors. Hematol Oncol Clin North Am 2007; 21: 409-32.
19. Zhang LH, Chu Q, Huang ZY. Diagnostic effect of NSE, CgA, SYP in neuroendocrine carcinoma. Shanghai Med J 1997; 20: 660-1.
20. Iwao M, Nakamuta M, Enjoji M, et al. Primary hepatic neuroendocrine tumor: case report and review of 53 cases. Med Sci Monit 2001; 7: 746-50.
21. Knox CD, Anderson CD, Lamps LW, et al. Long-term survival after resection for primary hepatic carcinoid tumor. Ann Surg Oncol 2003; 10: 1171-5.
22. Woodside KJ, Townsend CM, Evers BM. Current management of gastrointestinal carcinoid tumors. J Gastrointest Surg 2004; 8: 742-56.
23. Maroun J, Kocha W, Kvols L, et al. Guidelines for the diagnosis and management of carcinoid tumors. Part I: The gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group. Curr Oncol 2006; 13: 67-76.
24. Kvols LK, Moertel CG, O'Connell MJ, et al. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. N Engl J Med 1986; 315: 663-6.
25. Iimuro Y, Deguchi Y, Ueda Y, et al. Primary hepatic neuroendocrine tumor with metachronous lymph node metastasis after long-term follow up. J Gastroenterol Hepatol 2002; 17: 1119-24.
26. Bastaki W, Mothaffer F, Varro J, et al. Primary hepatic carcinoid tumor. Med Princ Pract 2005; 90: 3392-400.
27. Stridsberg M, Eriksson B, Oberg K, Janson ET. A comparison between three commercial kits for chromogranin A measurements. J Endocrinol 2003; 177: 337-41.
28. Yao KA, Talamonti MS, Nemcek A, et al. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery 2001; 130: 677-85.